期刊文献+

以树突状细胞为基础的前列腺癌免疫治疗的研究

The Experimental Study About the Immunizing Treatment of Prostate Cancer Induced By Sensitized DC
下载PDF
导出
摘要 探讨以人外周血单个核细胞(peripheral blood monouclear cells,PBMC)来源的树突状细胞(dendritic cell,DC)为基础的抗前列腺癌免疫作用。分离外周血PBMC,用重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)和重组人白介素-4(rhIL-4)诱导PBMC产生DC。提取前列腺癌PC-3细胞总RNA,致敏DC并用流式细胞仪检测细胞的表面标志物CD14、CD40、CD80、CD86。致敏后的DC与淋巴细胞共同培养诱导产生特异性细胞毒性T淋巴细胞(cytotoxicTlym-phocyte,CTL),用MTT细胞毒检测试剂盒检测特异性CTL对肿瘤细胞的杀伤率。结果总RNA致敏后的DC细胞CD40、CD80、CD86显著增高,CD14显著降低(P<0.05)。前列腺癌组杀伤率(55.27+9.76)与空白对照组杀伤率(36.75+7.06)之间的差异有统计学意义(P=0.009<0.05)。胃癌对照组杀伤率(36.75+7.06)与空白对照组杀伤率(35.66+7.85)之间差异无统计学意义(P=0.834>0.05)。结论是经RNA致敏的DC可以诱导产生对前列腺癌细胞有特异性杀伤活性的CTL。 To investigate the anti-tumor effects of cytotoxic T lymphocyte(CTL) induced by sD.C. DC was induced from peripheral blood monouclear cells(PBMC) by combined rhIL-4 and rhGM-CSF. Abstract mRNA from prostate cancer cells,and sensitize DC with it. DC sensitized by mRNA(sDC)would be detected by a flow cytometer which could monitor its surface marker CD14,CD40,CD80 and CD86. sDC and lymphocyte were co-cultured to induce CTL. The anti-tumor effects of CTL was measured by using MTT kit. CD40 ,CD80 and CD86 increased significantly and CD14 decreased significantly(P%0.05). There was significant difference between kill-rates of the prostate cancer groups and that of blank groups(P= 0. 009〈0. 05), and no significant difference between stomach cancer groups and blank groups( P= 0. 843〉 0.05). Therefore,sDC could induce CTL which had specific action killing cancer cells.
出处 《医学与哲学(B)》 2008年第12期32-33,36,共3页 Medicine & Philosophy(B)
关键词 前列腺癌 树突状细胞 淋巴细胞 prostate cancer, DC, lymphocyte
  • 相关文献

参考文献1

二级参考文献8

  • 1徐琪 邵莹 张乃宁etal.肿瘤患者自体树突状细胞的建立[J].中国肿瘤生物治疗杂志,1999,6(3):212-212.
  • 2Lu D, Benjamin R, Kim M, et al. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors [J]. Cancer Gene Ther, 1994, 1(4):245
  • 3Nair SK, Boczkowski D, Morse M, et al. Induction of primary carcinoembryonic antigen(CEA)-specific cytotoxiv T lymphocytes in vitro using human dendritic cells transfected with RNA[J]. Nat Biotechnol, 1998,16(4):364
  • 4Mitchell DA, Nair SK. RNA-transfected dendfiticcells in cancer immunotherapy[J]. J Clin Invest, 2000, 106(9): 1065
  • 5Boczkowski D, Nair ST, Nam JH, et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplifided from tumor cells [J]. Cancer Res, 2000, 60(4):1028
  • 6Tarte K, Klein B. Dendritic cell-based vaccines: a promising approach for cancer immunotherapy[J]. Leukemia, 1999, 13(5):653
  • 7Kuppner MC, Gastpar R, Gelwer S, et al. The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors [J]. Eur J Immunol, 2001,31(5):1602
  • 8Heiser A, Maurice MA, Yancey DR, et al. Human dendritic cells transfeeted with renal tumor RNA stimulate polyelonal T-cell responses against antigens expressed by primary and metastatic tumors [J]. Cancer Res, 2001 ,61(8):3388

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部